Showing results (651-660 of 1,033) with videos related to

Sort By:
Pageof 104
The Lancet. Respiratory Medicine|September 26, 2020
COVID-19 among people experiencing homelessness in England: a modelling studyDan Lewer, Isobel Braithwaite, Miriam Bullock, et al.
The Lancet. Respiratory Medicine|December 28, 2020
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trialTim W Harrison, Pascal Chanez, Francesco Menzella, et al.
The Lancet. Respiratory Medicine|December 20, 2020
Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort studyLionel Piroth, Jonathan Cottenet, Anne-Sophie Mariet, et al.
The Lancet. Respiratory Medicine|December 7, 2020
Clinical impact of a routine, molecular, point-of-care, test-and-treat strategy for influenza in adults admitted to hospital (FluPOC): a multicentre, open-label, randomised controlled trialTristan W Clark, Kate R Beard, Nathan J Brendish, et al.
The Lancet. Respiratory Medicine|September 8, 2022
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 studyJoshua J Solomon, Sonye K Danoff, Felix A Woodhead, et al.
The Lancet. Respiratory Medicine|September 8, 2022
Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trialHolly R Keir, Merete B Long, Hani Abo-Leyah, et al.
The Lancet. Respiratory Medicine|January 25, 2021
Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial
The Lancet. Respiratory Medicine|January 18, 2021
Characterisation of the first 250,000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide dataOtavio T Ranzani, Leonardo S L Bastos, João Gabriel M Gelli, et al.
The Lancet. Respiratory Medicine|November 12, 2021
Non-invasive respiratory support in the management of acute COVID-19 pneumonia: considerations for clinical practice and priorities for researchSampath Weerakkody, Pietro Arina, James Glenister, et al.
The Lancet. Respiratory Medicine|January 31, 2021
Long-term safety and efficacy of lumacaftor-ivacaftor therapy in children aged 6-11 years with cystic fibrosis homozygous for the F508del-CFTR mutation: a phase 3, open-label, extension studyMark A Chilvers, Jane C Davies, Carlos Milla, et al.
Pageof 104